How PlexusDx Supports a More Personalized Approach Both Ro and Brello provide valuable telehealth pathways to GLP-1 access, yet neither integrates genetic peptide pathway testing into standard workflows
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): A phase 3, double-blind, randomised, multicentre, placebo-controlled trial
26 The majority (67%) of the patients reviewed had a mean baseline HbA1c of 9.5% when therapy was initiated, which supports the theory of lack of action in response to abnormal findings
Genetically manipulated progenitor cell sheet with diprotin a improves myocardial function and repair of infarcted hearts
This guide explains everything you need to know about vaccines during pregnancy, including safety, timing, benefits, and what to discuss with your healthcare provider